|
BCL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.928200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.446600E-01 |
| Normal-vs-Stage2 |
3.480200E-01 |
| Normal-vs-Stage3 |
2.842100E-02 |
| Normal-vs-Stage4 |
5.560800E-03 |
| Stage1-vs-Stage2 |
1.828630E-01 |
| Stage1-vs-Stage3 |
1.381810E-03 |
| Stage1-vs-Stage4 |
2.14419999999826E-05 |
| Stage2-vs-Stage3 |
3.807800E-01 |
| Stage2-vs-Stage4 |
1.613960E-01 |
| Stage3-vs-Stage4 |
3.968400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.679400E-01 |
| Normal-vs-AfricanAmerican |
6.198100E-02 |
| Normal-vs-Asian |
2.834200E-01 |
| Caucasian-vs-AfricanAmerican |
1.243800E-01 |
| Caucasian-vs-Asian |
4.122800E-01 |
| AfricanAmerican-vs-Asian |
8.451000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.788170E-01 |
| Normal-vs-Female |
3.170600E-01 |
| Male-vs-Female |
6.910000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.087200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.410600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.344170E-01 |
| Normal-vs-Age(81-100Yrs) |
2.244400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.382200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.981800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.743000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.806000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.082400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.508600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.383600E-01 |
| Normal-vs-Grade 2 |
5.672200E-01 |
| Normal-vs-Grade 3 |
1.966340E-02 |
| Normal-vs-Grade 4 |
1.540980E-03 |
| Grade 1-vs-Grade 2 |
3.617200E-01 |
| Grade 1-vs-Grade 3 |
1.541750E-03 |
| Grade 1-vs-Grade 4 |
1.581390E-04 |
| Grade 2-vs-Grade 3 |
3.4359999999678E-06 |
| Grade 2-vs-Grade 4 |
2.42100000047429E-07 |
| Grade 3-vs-Grade 4 |
1.060400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.035400E-01 |
| Normal-vs-ccB subtype |
3.926300E-02 |
| ccA subtype-vs-ccB subtype |
2.02999999999731E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.658040E-01 |
| Normal-vs-N1 |
9.680200E-02 |
| N0-vs-N1 |
2.515600E-01 |
|
|
